Cargando…
Soluble factors produced by PC-3 prostate cells decrease collagen content and mineralisation rate in fetal rat osteoblasts in culture.
Approximately 70% of patients with prostate cancer develop bone metastases in the advanced state of the disease. In the present study, we sought to test the hypothesis that prostatic cancer cells produce factors that inhibit the mineralisation process in vitro, decreasing the content of type I colla...
Autores principales: | Santibáñez, J. F., Silva, S., Martínez, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074652/ https://www.ncbi.nlm.nih.gov/pubmed/8695358 |
Ejemplares similares
-
Associated changes in stiffness of collagen scaffolds during osteoblast mineralisation and bone formation
por: Bakkalci, Deniz, et al.
Publicado: (2022) -
Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1
por: Yuen, H-F, et al.
Publicado: (2010) -
Prostate Cancer Cell Extracellular Vesicles Increase Mineralisation of Bone Osteoblast Precursor Cells in an In Vitro Model
por: Lanning, Ben, et al.
Publicado: (2021) -
Human osteoblasts within soft peptide hydrogels promote mineralisation in vitro
por: Castillo Diaz, Luis A, et al.
Publicado: (2014) -
DP2, a Carbohydrate Derivative, Enhances In Vitro Osteoblast Mineralisation
por: Ballout, Nissrine, et al.
Publicado: (2023)